VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $271,539,908 | -0.5% | 5,122,428 | +54.0% | 0.01% | 0.0% |
Q1 2024 | $272,778,494 | +155.7% | 3,326,567 | -42.0% | 0.01% | +140.0% |
Q4 2023 | $106,690,944 | +50.3% | 5,732,990 | -10.6% | 0.01% | +25.0% |
Q3 2023 | $70,970,456 | -9.2% | 6,411,062 | +33.0% | 0.00% | 0.0% |
Q2 2023 | $78,122,085 | -11.2% | 4,819,376 | -8.7% | 0.00% | -20.0% |
Q1 2023 | $87,927,718 | +1794.7% | 5,280,944 | +969.7% | 0.01% | – |
Q4 2022 | $4,640,630 | +591.6% | 493,684 | +100.0% | 0.00% | – |
Q3 2022 | $671,000 | -11.0% | 246,842 | -5.4% | 0.00% | – |
Q2 2022 | $754,000 | -81.5% | 261,042 | -80.8% | 0.00% | – |
Q1 2022 | $4,072,000 | -78.5% | 1,357,176 | -67.1% | 0.00% | -100.0% |
Q4 2021 | $18,978,000 | -25.2% | 4,125,567 | +2.1% | 0.00% | 0.0% |
Q3 2021 | $25,385,000 | -15.0% | 4,042,251 | -18.9% | 0.00% | -50.0% |
Q2 2021 | $29,866,000 | -30.4% | 4,985,960 | -26.5% | 0.00% | 0.0% |
Q1 2021 | $42,912,000 | +50.3% | 6,784,444 | +33.7% | 0.00% | 0.0% |
Q4 2020 | $28,558,000 | -3.0% | 5,072,556 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $29,439,000 | -4.5% | 5,058,164 | +18.3% | 0.00% | 0.0% |
Q2 2020 | $30,835,000 | +80.9% | 4,276,762 | +17.4% | 0.00% | +100.0% |
Q1 2020 | $17,044,000 | -41.1% | 3,641,950 | +0.9% | 0.00% | -50.0% |
Q4 2019 | $28,954,000 | +9.0% | 3,610,262 | -6.5% | 0.00% | 0.0% |
Q3 2019 | $26,563,000 | -53.8% | 3,860,870 | -44.3% | 0.00% | -50.0% |
Q2 2019 | $57,539,000 | -19.9% | 6,932,425 | -4.1% | 0.00% | -33.3% |
Q1 2019 | $71,845,000 | +38.9% | 7,227,888 | +6.9% | 0.01% | +20.0% |
Q4 2018 | $51,725,000 | -50.9% | 6,761,485 | +11.7% | 0.01% | -37.5% |
Q3 2018 | $105,451,000 | +1418.8% | 6,053,551 | +727.5% | 0.01% | +700.0% |
Q2 2018 | $6,943,000 | +4859.3% | 731,568 | +2193.3% | 0.00% | – |
Q1 2018 | $140,000 | – | 31,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |